Pharmacy Times
MAY 12, 2025
A panelist discusses how physicians can collaborate with community pharmacists to enhance respiratory syncytial virus (RSV) vaccine uptake by leveraging pharmacists' expertise in patient education, addressing vaccine hesitancy through empathetic communication, and emphasizing the safety, benefits, and risks of RSV vaccination.
Drug Topics
MAY 13, 2025
Pharmacist-led interventions improve medication adherence compared with the usual care for patients with heart failure and type 2 diabetes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
MAY 13, 2025
New research has proposed a novel approach for treating early-stage breast cancer with inherited BRCA1 and BRCA2 gene mutations. One hundred percent of patients survived three-years post-surgery, indicating the most effective treatment to date for this indication. Current standard treatment involves chemotherapy and immunotherapy to shrink the tumour, before surgical removal.
Fierce Healthcare
MAY 12, 2025
The already massive nonprofit has grown substantially since the start of last year, though its operating performance and bottom line were both down.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
MAY 12, 2025
A panelist discusses how physicians can navigate respiratory syncytial virus (RSV) vaccine selection by considering patient age, pregnancy status, and seasonality, highlighting the approved indications for Arexvy and Abrysvo, including maternal immunization to protect infants through passive immunity.
Drug Topics
MAY 14, 2025
Investigators also find that patients diagnosed with type 1 diabetes later in life do not have a better prognosis compared to those diagnosed earlier.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Marketing Network
MAY 11, 2025
Imagine building a skyscraper only to find the foundation cracking beneath your feet. Thats how investors are feeling about Asian pharma stocks right now. As the U.S. accelerates its crackdown on drug pricing through new legislation and regulatory enforcement, pharma companies in China, India, Japan, and South Korea are feeling the ripple effect. Despite years of bullish momentum, the Asian pharma sector has taken a hit in 2024and the pain may not be short-lived.
Pharmacy Times
MAY 12, 2025
PharmStart empowers pharmacy technicians to pursue their education with tuition-free prerequisites, addressing barriers to entering pharmacy school.
The Checkup by Singlecare
MAY 12, 2025
MiraLax is a popular brand-name, over-the-counter (OTC) laxative that helps relieve constipation. Containing the active ingredient polyethylene glycol 3350 (PEG 3350), MiraLax is FDA approved to treat occasional constipation in adults. It has several off-label uses, too, including treating chronic constipation, constipation related to irritable bowel syndrome (IBS), bowel preparation for colonoscopy procedures, and treating constipation in children (which the American Academy of Pediatrics consi
STAT
MAY 13, 2025
For a recent therapy session, Andria Donaghy’s insurance plan paid her psychiatric nurse practitioner only $11 on a $125 service. “To even put that on paper is insulting,” she said. “These people give their lives [to help others] and that’s what you pay them?
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
MAY 12, 2025
Tirzepatide (Zepbound) demonstrated superiority compared to semaglutide (Wegovy) across the primary end point and 5 key secondary end points.
Pharmacy Times
MAY 12, 2025
Panelists discuss how evidence from a value-based care perspective demonstrates long-term health benefits, including reduced recurrent events and hospitalizations, as well as cost savings associated with intensive low-density lipoprotein cholesterol (LDL-C)lowering therapies beyond statins in patients who are very high-risk post-atherosclerotic cardiovascular disease (ASCVD), while also addressing key challenges health care providers face in selecting nonstatin therapies and strategies to overco
Pharma Marketing Network
MAY 15, 2025
In a world of podcasts , reels, and AI-written content, its fair to ask: are white papers still pulling their weight in pharma marketing? For teams navigating omnichannel campaigns, strict MLR approvals, and buyer fatigue, the answer isn’t just “yes”it’s if done right, they work better than ever. Once the domain of technical audiences and B2B legacy brands, white papers have evolved.
Hospital Pharmacy Europe
MAY 15, 2025
One in three pharmacists in Great Britain (34%) are now independent prescribers, according to recent data from the General Pharmaceutical Council (GPhC). As of 31 March 2025, some 21,804 pharmacists now have an independent prescriber annotation, representing33% of all registered pharmacists in Great Britain, the data shows. However, the number of independent prescribers varies across England, Wales and Scotland.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
MAY 12, 2025
House Republicans have unveiled their plans to cut federal spending and extend tax cuts, but experts warn that funding the cuts by slashing Medicaid and other entitlements will largely benefit families with higher incomes.
Pharmacy Times
MAY 13, 2025
FDA and CDC halt Ixchiq chikungunya vaccine for adults 60 years and older due to severe adverse events, including fatalities, urging caution in vaccination practices.
Drug Topics
MAY 12, 2025
Investigators find that unhealthy eating and inadequate or excessive sleeping duration could contribute to developing diabetic nephropathy.
The Checkup by Singlecare
MAY 15, 2025
Wegovy (semaglutide) is a once-weekly weight-loss medication that belongs to a class of drugs called GLP-1 agonists. It is FDA approved for weight management and to reduce the risk of stroke, heart attack , or other cardiovascular death in people who are overweight or have obesity. Wegovy is self-injected at home, so users must know how to properly store their single-dose injector pens before use.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
MAY 13, 2025
The CMS Innovation Center rolled out its blueprint to reverse chronic disease and test more effective payment models Tuesday.
Pharmacy Times
MAY 12, 2025
During a panel discussion, 3 experts highlighted ways health care professionals and researchers can help provide patient-centered care.
STAT
MAY 14, 2025
Drug deaths plummeted in 2024, according to new federal data. An estimated 80,391 people died of a drug overdose in the U.S. last year, marking the lowest total since 2019. The sum represents a roughly 27% decrease from 2023, according to the Centers for Disease Control and Prevention.
PharmExec
MAY 14, 2025
Results from the Phase III REAL8 basket study found that once-weekly Sogroya was effective in children with growth disorders, including those born small for gestational age, with Noonan syndrome, or idiopathic short stature.
Pharmaceutical Technology
MAY 13, 2025
The FDA has cleared the IND for Ensoma's EN-374, targeting X-linked chronic granulomatous disease (X-CGD), a rare genetic disorder.
Pharmacy Times
MAY 14, 2025
The announcement came shortly before updated results from the SURMOUNT-5 clinical trial, which found Zepbound had superior weight-loss effects over Wegovy.
The Checkup by Singlecare
MAY 13, 2025
If you have certain lung conditions, you may be prescribed a Dulera inhaler. Dulera is a prescription medication that combines two active ingredients: formoterol fumarate dihydrate and mometasone. It is FDA approved to help manage symptoms of asthma and improve lung function in adults and pediatric patients five years of age and older. Dulera is also prescribed off-label to help with breathing problems in adults with chronic obstructive pulmonary disorder (COPD).
pharmaphorum
MAY 14, 2025
Andrew Witty has resigned as CEO of US health conglomerate UnitedHealth, as the company pulled its financial forecasts for 2025
STAT
MAY 13, 2025
Leading trade organizations representing the makers of cell and gene therapies are calling for a 10-year international moratorium on the use of CRISPR and other DNA-editing tools to create genetically modified children, according to a draft of the declaration provided to STAT. The move — coming more than seven years after Chinese researcher He Jiankui announced the birth of the world’s first CRISPR babies — is intended to send a clear signal to the global scientific co
Pharmacy Times
MAY 14, 2025
Like other high-risk groups, children with sickle cell disease have a heightened risk of invasive pneumococcal disease, even if they receive proper pneumococcal conjugate vaccine coverage.
Pharmafile
MAY 13, 2025
Newron Pharmaceuticals has announced the approval for its ENIGMA-TRS phase 3 development programme evaluating evenamide as an add-on therapy to current antipsychotics in patients with treatment-resistant schizophrenia (TRS). This is a significant milestone Newrons endeavour to rollout the therapy as a conventional treatment for these patients. The ENIGMA-TRS phase 3 development programme consists of two […] The post Newrons programme for treatment-resistant schizophrenia therapy approved a
Fierce Healthcare
MAY 15, 2025
Iodine Software's pre-bill solution can identify an extra 25% revenue savings per month for health systems after a patient is discharged. The savings could help justify investment in other AI products.
Pharmaceutical Technology
MAY 14, 2025
The deal comes at a time of revival into liver disease treatment investment as market opportunity beckons.
Pharmacy Times
MAY 13, 2025
Artificial intelligence (AI) can transform rare disease research by leveraging patient data, enhancing evidence generation, and improving communication between patients and health care professionals.
Drug Topics
MAY 12, 2025
Douglas Hoey, CEO of NCPA, discusses what independent pharmacies can do to handle an influx of patients and what the chains situation means for the pharmacy landscape.
Expert insights. Personalized for you.
65 
Let's personalize your content